Market Cap 61.02B
Revenue (ttm) 14.20B
Net Income (ttm) 4.41B
EPS (ttm) N/A
PE Ratio 15.08
Forward PE 18.21
Profit Margin 31.07%
Debt to Equity Ratio 0.07
Volume 875,400
Avg Vol 1,036,166
Day's Range N/A - N/A
Shares Out 105.99M
Stochastic %K 68%
Beta 0.31
Analysts Strong Sell
Price Target $730.42

Company Profile

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to...

Industry: Biotechnology
Sector: Healthcare
Phone: 914 847 7000
Address:
777 Old Saw Mill River Road, Tarrytown, United States
SuperGreenToday
SuperGreenToday Oct. 25 at 1:24 AM
$REGN Share Price: $578.09 Contract Selected: Nov 21, 2025 $580 Calls Buy Zone: $20.48 – $25.31 Target Zone: $36.20 – $44.24 Potential Upside: 67% ROI Time to Expiration: 27 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OTCMOBSTER
OTCMOBSTER Oct. 24 at 9:29 PM
$REGN My grandfather passed down some $REGN shares he’d been holding since 1994, and they’re now helping fund my retirement. I’m looking for some hidden gems to research and hold long-term—say, for the next 20 years. Any ideas worth doing some DD on?
1 · Reply
OX50
OX50 Oct. 24 at 9:08 PM
$REGN Latest Report 10/24/2025 LSEG maintains a current price target of $733.14 for REGN
0 · Reply
MahiMe
MahiMe Oct. 24 at 8:06 PM
$REGN https://finance.yahoo.com/news/long-leaf-partners-fund-regeneron-171424649.html Longleaf Partners Fund stated the following regarding Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) in its third quarter 2025 investor letter: "After a slow start to our holding period this year, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has found its footing and grown its value per share back to above where we started the year in our opinion. We still do not have to pay anything for multiple high quality pipeline candidates, and the company has become one of our larger share repurchasers with its net cash balance sheet."
0 · Reply
BryanNewton
BryanNewton Oct. 24 at 7:57 PM
$REGN I heard the company is doing well. They got some nice drugs coming in their pipeline
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 7:51 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $REGN Current Share Price: $573.95 Contracts: $REGN December 18, 2026 $580 Calls Scale in: $93.60- $114.40 Scale out: $145.60-$187.20 Can Easily Capture: 60% ROI Blended DTE: 421 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
MahiMe
MahiMe Oct. 24 at 6:12 PM
$REGN giddy up. 585+.. today
0 · Reply
Bullish_Trader555
Bullish_Trader555 Oct. 24 at 2:44 PM
0 · Reply
Bullish_Trader555
Bullish_Trader555 Oct. 24 at 2:09 PM
$MRUS Interim Data on Petosemtamab in Metastatic Colorectal Cancer Demonstrates Monotherapy Activity and Robust Response Rate in Combination with FOLFOX/FOLFIRI with Well Tolerated Safety – 100% response rate in 1L left-sided mCRC (n=8, confirmed and unconfirmed) - $SPY $LLY $REGN
0 · Reply
MahiMe
MahiMe Oct. 24 at 1:00 PM
$REGN Canaccord Genuity has maintained a "Buy" rating for Regeneron Pharmaceuticals (REGN) with a price target of $850, as of an analyst note published on October 23, 2025
0 · Reply
Latest News on REGN
7 Stocks Taking The Next Step To Be On Offense

Oct 23, 2025, 7:30 PM EDT - 1 day ago

7 Stocks Taking The Next Step To Be On Offense

ACI BIO CNX FCF FDX FIS IAC


11 Cheap Stocks for a Market That's Too Expensive

Oct 7, 2025, 11:49 AM EDT - 18 days ago

11 Cheap Stocks for a Market That's Too Expensive

DAL FDX UAL


Regeneron: Growth Catalysts Incoming

Sep 30, 2025, 4:25 PM EDT - 24 days ago

Regeneron: Growth Catalysts Incoming


Regeneron: Strong R&D Pipeline Drives Growth Outlook

Sep 27, 2025, 9:00 AM EDT - 4 weeks ago

Regeneron: Strong R&D Pipeline Drives Growth Outlook


Regeneron: EYLEA's Decline Is Masking A Deep Value Opportunity

Aug 11, 2025, 11:36 AM EDT - 2 months ago

Regeneron: EYLEA's Decline Is Masking A Deep Value Opportunity


Regeneron: Rapidly Decreasing Importance Of Eylea

Aug 1, 2025, 4:05 PM EDT - 3 months ago

Regeneron: Rapidly Decreasing Importance Of Eylea


SuperGreenToday
SuperGreenToday Oct. 25 at 1:24 AM
$REGN Share Price: $578.09 Contract Selected: Nov 21, 2025 $580 Calls Buy Zone: $20.48 – $25.31 Target Zone: $36.20 – $44.24 Potential Upside: 67% ROI Time to Expiration: 27 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OTCMOBSTER
OTCMOBSTER Oct. 24 at 9:29 PM
$REGN My grandfather passed down some $REGN shares he’d been holding since 1994, and they’re now helping fund my retirement. I’m looking for some hidden gems to research and hold long-term—say, for the next 20 years. Any ideas worth doing some DD on?
1 · Reply
OX50
OX50 Oct. 24 at 9:08 PM
$REGN Latest Report 10/24/2025 LSEG maintains a current price target of $733.14 for REGN
0 · Reply
MahiMe
MahiMe Oct. 24 at 8:06 PM
$REGN https://finance.yahoo.com/news/long-leaf-partners-fund-regeneron-171424649.html Longleaf Partners Fund stated the following regarding Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) in its third quarter 2025 investor letter: "After a slow start to our holding period this year, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has found its footing and grown its value per share back to above where we started the year in our opinion. We still do not have to pay anything for multiple high quality pipeline candidates, and the company has become one of our larger share repurchasers with its net cash balance sheet."
0 · Reply
BryanNewton
BryanNewton Oct. 24 at 7:57 PM
$REGN I heard the company is doing well. They got some nice drugs coming in their pipeline
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 7:51 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $REGN Current Share Price: $573.95 Contracts: $REGN December 18, 2026 $580 Calls Scale in: $93.60- $114.40 Scale out: $145.60-$187.20 Can Easily Capture: 60% ROI Blended DTE: 421 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
MahiMe
MahiMe Oct. 24 at 6:12 PM
$REGN giddy up. 585+.. today
0 · Reply
Bullish_Trader555
Bullish_Trader555 Oct. 24 at 2:44 PM
0 · Reply
Bullish_Trader555
Bullish_Trader555 Oct. 24 at 2:09 PM
$MRUS Interim Data on Petosemtamab in Metastatic Colorectal Cancer Demonstrates Monotherapy Activity and Robust Response Rate in Combination with FOLFOX/FOLFIRI with Well Tolerated Safety – 100% response rate in 1L left-sided mCRC (n=8, confirmed and unconfirmed) - $SPY $LLY $REGN
0 · Reply
MahiMe
MahiMe Oct. 24 at 1:00 PM
$REGN Canaccord Genuity has maintained a "Buy" rating for Regeneron Pharmaceuticals (REGN) with a price target of $850, as of an analyst note published on October 23, 2025
0 · Reply
RyanWalker8333
RyanWalker8333 Oct. 23 at 9:49 PM
Instinct: pressure building, could ignite fast! Portfolio: $GS $BNTX $REGN $SAP $RIO Why this cluster: Liquidity profile looks favorable for quick repricing once momentum confirms. GS shows relative strength; BNTX is base-building; REGN is a stealth accumulator; SAP offers sector exposure; RIO provides stability. Execution: Execution: define stop levels, use partial profit-taking on initial leg. #StocksToWatch #Momentum Source: https://stocktwits.com/JacquelineBryant4972/message/632828478
0 · Reply
KayleeAcosta1722
KayleeAcosta1722 Oct. 23 at 8:18 PM
High-conviction cluster — risk-defined entries only! Portfolio: $PANW $BA $REGN $EXC $SLB Why this cluster: Sector strength aligning with positive sentiment; disciplined entries and stops recommended. PANW shows relative strength; BA is base-building; REGN is a stealth accumulator; EXC offers sector exposure; SLB provides stability. Execution: Execution: define stop levels, use partial profit-taking on initial leg. #TradeSetup #Watchlist Source: https://stocktwits.com/GaryBrown7417/message/632828520
2 · Reply
OX50
OX50 Oct. 23 at 7:25 PM
$REGN Fidelity has REGN score on a very high bullish rating. Time to load up huge. Very Bullish 9.6 out of 10
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Oct. 23 at 5:54 PM
$REGN has anybody contacted investor relations regarding when they will resume production of Eylea HD dual syringe at the Catalent facility? This is taking way longer than Len said during his last Quarterly call.
0 · Reply
DannySmith6941
DannySmith6941 Oct. 23 at 4:56 PM
High-conviction cluster — risk-defined entries only! Portfolio: $FTNT $OKTA $MRK $REGN $ABNB Why this cluster: Sector strength aligning with positive sentiment; disciplined entries and stops recommended. FTNT shows relative strength; OKTA is base-building; MRK is a stealth accumulator; REGN offers sector exposure; ABNB provides stability. Execution: Tip: scale in with size discipline; add on volume-confirmed strength. #RiskManaged #TopPicks Source: https://stocktwits.com/JacquelineBryant4972/message/632828478
0 · Reply
Yeueehehe
Yeueehehe Oct. 23 at 4:29 PM
$REGN welcome to the hell bro
1 · Reply
KristenVillanueva2032
KristenVillanueva2032 Oct. 23 at 4:16 PM
Tape is smoking — catalysts near, volume rising! Portfolio: $GOOGL $HAL $BKNG $LI $REGN Why this cluster: Sector strength aligning with positive sentiment; disciplined entries and stops recommended. GOOGL shows relative strength; HAL is base-building; BKNG is a stealth accumulator; LI offers sector exposure; REGN provides stability. Execution: Plan: small starter position, scale with a confirmed trend; respect risk. #StocksToWatch #Momentum Source: https://stocktwits.com/TiffanyLawson6758/message/632828686
0 · Reply
BryanNewton
BryanNewton Oct. 23 at 2:34 PM
$REGN what a garbage stock. Can't even go green when markets are ripping. Falls harder when markets are bleeding
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Oct. 23 at 2:26 PM
$REGN still holding this thing hostage...
0 · Reply
MahiMe
MahiMe Oct. 23 at 1:36 PM
$REGN Canaccord Genuity maintains a Buy rating on Regeneron Pharmaceuticals (REGN) with a price target of $850 on oct 23,2025.
0 · Reply
JarvisFlow
JarvisFlow Oct. 23 at 1:04 PM
Canaccord Genuity has updated their rating for Regeneron Pharmaceuticals ( $REGN ) to Buy with a price target of 850.
0 · Reply
MahiMe
MahiMe Oct. 23 at 11:46 AM
$REGN https://www.marketbeat.com/instant-alerts/filing-regeneron-pharmaceuticals-inc-regn-stock-holdings-increased-by-ethic-inc-2025-10-23/
0 · Reply